Cite
HARVARD Citation
Postow, M. et al. (n.d.). 434 Updated clinical data from the melanoma expansion cohort of an ongoing Ph1/1b Study of eganelisib (formerly IPI-549) in combination with nivolumab. Journal for immunotherapy of cancer. pp. A264-A265. [Online].